Arthritis Research & Therapy (Jan 2024)
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression
- Lichong Shen,
- Hanlin Yin,
- Li Sun,
- Zhiliang Zhang,
- Yuyang Jin,
- Shan Cao,
- Qiong Fu,
- Chaofan Fan,
- Chunde Bao,
- Liangjing Lu,
- Yifan Zhan,
- Xiaojiang Xu,
- Xiaoxiang Chen,
- Qingran Yan
Affiliations
- Lichong Shen
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Hanlin Yin
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Li Sun
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Wenzhou Medical University
- Zhiliang Zhang
- Department of Plastic Surgery, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Yuyang Jin
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Shan Cao
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Qiong Fu
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Chaofan Fan
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Chunde Bao
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Liangjing Lu
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Yifan Zhan
- Department of Drug Discovery, Shanghai Huaota Biopharm
- Xiaojiang Xu
- Department of Pathology and Laboratory Medicine, Tulane University School of Medicine
- Xiaoxiang Chen
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- Qingran Yan
- Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
- DOI
- https://doi.org/10.1186/s13075-024-03268-y
- Journal volume & issue
-
Vol. 26,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
